The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
Open accessAbstract
Proliferating mammalian cells use glutamine as a source of nitrogen and as a key anaplerotic source to provide metabolites to the tricarboxylic acid cycle (TCA) for biosynthesis. Recently, mammalian target of rapamycin complex 1 (mTORC1) activation has been correlated with increased nutrient uptake and metabolism, but no molecular connection to glutaminolysis has been reported. Here, we show that mTORC1 promotes glutamine anaplerosis by activating glutamate dehydrogenase (GDH). This regulation requires transcriptional repression of SIRT4, the mitochondrial-localized sirtuin that inhibits GDH. Mechanistically, mTORC1 represses SIRT4 by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 (CREB2). Thus, a relationship between mTORC1, SIRT4, and cancer is suggested by our findings. Indeed, SIRT4 expression is reduced in human cancer, and its overexpression reduces cell proliferation, transformation, and tumor development. Finally, our data indicate that targeting nutrient metabolism in energy-addicted cancers with high mTORC1 signaling may be an effective therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mTORC1, which is well known for its function at the center of cancer metabolic reprogramming, promotes mitochondrial glutaminolysis via the migration of SIRT4-mediated inhibition of GLUD1189.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [189]
In the citing paper
“SIRT4 likewise appears to control tumorigenesis ((Jeong et al. 2013), (Csibi et al. 2013)) by inhibiting the high rate of glutamine metabolism associated with cancer growth;”
From The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications (2018) · cites this paper as Csibi et al. 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 587
Ma, Y., Li, Y., Ling, S., Li, X., Kong, B., Hu, M., & Huang, P. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.137 · Cited by 12
Pharmacologic inhibition of mTORC1 mimics dietary protein restriction in a mouse model of lactation
Pszczolkowski, V. L., Halderson, S. J., Meyer, E. J., Lin, A., & Apelo, S. I. A. (2020) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-020-00470-1 · Cited by 13
Wang, H., Li, J., Huang, R., Fang, L., & Yu, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.666630 · Cited by 12
mTOR activation is critical for betulin treatment in renal cell carcinoma cells
Cheng, W., Ji, S., Zhang, H., Han, Z., Liu, Q., Wang, J., & Ping, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.153 · Cited by 12
Wang, C., Piao, C., Liu, J., Zhang, Z., Zhu, Y., & Kong, C. (2020) · Cancer Biomarkers · doi:10.3233/cbm-191253 · Cited by 12
Dutra, H. L. C., Deehan, M., & Frydman, H. M. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008996 · Cited by 12
Takahashi, K., Tsuji, M., Nakagawasai, O., Katsuyama, S., Hong, L., Miyagawa, K., Kurokawa, K., Mochida-Saito, A., Takeda, H., & Tadano, T. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114175 · Cited by 12
Sirtuins, Healthspan, and Longevity in Mammals
Giblin, W., & Lombard, D. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00003-4 · Cited by 12
How T'reg‐ulate healing of the injured spinal cord?
Milling, S. W. F., & Edgar, J. M. (2019) · Immunology · doi:10.1111/imm.13148 · Cited by 12
Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes
Kong, B. S., Lee, H., L’Yi, S., Hong, S., & Cho, Y. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01521-1 · Cited by 13
Mitochondrial DNA competition: starving out the mutant genome
Spinazzola, A., Pérez‐Rodríguez, D., Ježek, J., & Holt, I. J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.01.011 · Cited by 11
Chen, P., Ye, C., Huang, Y., Xu, B., Wu, T., Dong, Y., Jin, Y., Zhao, L., Hu, C., Mao, J., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00492-3 · Cited by 13
Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases
Ou, L., Liu, Y., Qiu, S.-T., Yang, C., Tang, J., Li, X., Liu, H., & Ye, Z.-N. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s471711 · Cited by 11
The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis
Pu, X., Wu, Y., Long, W., Sun, X., Yuan, X., Wang, D., Wang, X., & Xu, M. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03736-8 · Cited by 11
Arabidopsis thaliana sirtuins control proliferation and glutamate dehydrogenase activity
Bruscalupi, G., Micco, P. D., Failla, C. M., Pascarella, G., Morea, V., Saliola, M., Paolis, A. D., Venditti, S., & Mauro, M. L. (2022) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2022.11.007 · Cited by 11
Oncometabolic role of mitochondrial sirtuins in glioma patients
Haq, M. F. U., Hussain, M. Z., Mahjabeen, I., Akram, Z., Saeed, N., Shafique, R., Abbasi, S. F., & Kayani, M. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281840 · Cited by 11
mTORC2 Puts Its Shoulder to Krebs’ Wheel
Apelo, S. I. A., & Lamming, D. W. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.016 · Cited by 11
Kalim, K. W., Zhang, S., Chen, X., Li, Y., Yang, J., Zheng, Y., & Guo, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183266 · Cited by 11
Huang, M., Chang, J., Lin, W., Cheng, Y., Li, F., Suen, C., Hwang, M., Chang, C., & Mou, K. Y. (2020) · Chemistry - An Asian Journal · doi:10.1002/asia.202001056 · Cited by 11
Canceromics Studies Unravel Tumor’s Glutamine Addiction After Metabolic Reprogramming
Márquez, J., Matés, J. M., Alonso, F. J., Martín‐Rufián, M., Lobo, C., & Campos-Sandoval, J. A. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_12 · Cited by 11
A Mitochondrial Perspective on Noncommunicable Diseases
Zheng, Y., Zhang, J., Zhu, X., Wei, Y., Zhao, W., Si, S., & Li, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11030647 · Cited by 11
Wang, Y., Lu, Y., Fang, Z., Yan, H., Li, J., Ye, Z., Yu, Y., & Shan, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-55925-6 · Cited by 13
Yang, S.-L., Ma, B., Lu, Y.-S., Chen, J., Jiang, Y., Qiu, J. Y., Qian, Y., & Xu, Y. (2024) · Environment International · doi:10.1016/j.envint.2024.108778 · Cited by 10
A metabolomics comparison in milk from two Dezhou donkey strains
Li, Y., Ma, Q., Zhou, M.-M., Zhang, Z., Zhan, Y., Liu, G., Zhu, M.-X., & Wang, C. (2022) · European Food Research and Technology · doi:10.1007/s00217-022-03962-8 · Cited by 10
T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity
Bordignon, C., Canu, A., Dyczko, A., Leone, S., & Monti, P. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0848-5 · Cited by 10
Effectiveness and mechanism study of glutamine on alleviating hypermetabolism in burned rats
Yang, Y., Liu, M., Zhang, Y., Wang, Z. E., DanWu, Fan, S., Yan, W., Xia, L., & Peng, X. (2020) · Nutrition · doi:10.1016/j.nut.2020.110934 · Cited by 10
Verwer, E. E., Kavanagh, T. R., Mischler, W. J., Feng, Y., Takahashi, K., Wang, S., Shoup, T. M., Neelamegam, R., Yang, J., Guehl, N. J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3693 · Cited by 10
Mitra, S., Chaudhuri, R. D., Sarkar, R., Banerjee, S., Mukherjee, A., Sharma, R. P., Gope, A., Kitahara, K., Miyoshi, S.-I., & Chawla‐Sarkar, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2428425 · Cited by 9
Mao, L., Hong, X., Xu, L., Wang, X., Liu, J., Wang, H., Qian, Y., Zhao, J., & Jia, R. (2022) · Journal of Oncology · doi:10.1155/2022/5498743 · Cited by 9
Hesham, D., Mosaab, A., Amer, N., Al‐Shehaby, N., Magdeldin, S., Hassan, A., Georgiev, H., Elshoky, H. A., Rady, M., Abou‐Aisha, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-71188-7 · Cited by 9
Glutamine substitution: the role it can play to enhance therapeutic protein production
Ha, T. K., & Lee, G. M. (2015) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.15.6 · Cited by 9
Sirtuins in Brain and Neurodegenerative Disease
Szegő, É. M., Outeiro, T. F., & Kazantsev, A. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813499-3.00013-7 · Cited by 9
Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma
Liguori, L., Pastorino, F., Rousset, X., Alfano, S., Cortès, S., Emionite, L., Daga, A., Ponzoni, M., & Lenormand, J. (2015) · Molecules · doi:10.3390/molecules200915893 · Cited by 9
Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[18F]FGln PET Imaging
Li, C., Huang, S., Guo, J., Wang, C., Huang, Z., Huang, R., Liu, L., Liang, S., & Wang, H. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01330-9 · Cited by 9
Self-citationA ternary complex model of Sirtuin4-NAD+-Glutamate dehydrogenase
Kato, Y. S., Kihara, H., Fukui, K., & Kojima, M. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.03.006 · Cited by 9
Yang, G., Xiang, J., Yang, X., Liu, X., Li, Y., Li, L., Kang, L., Liang, Z., & Yang, S. (2024) · eLife · doi:10.7554/elife.98524 · Cited by 9
Yang, J., Chen, N., Zhao, P., Yang, X., Li, Y., Fu, Z., Yang, Y., Dong, N., Li, S., Yao, R.-Q., et al. (2024) · Shock · doi:10.1097/shk.0000000000002370 · Cited by 9
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors
Sui, Q., Yang, H., Hu, Z., Jin, X., Chen, Z., Jiang, W., & Sun, F. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03783-2 · Cited by 8
Bao, W., Liu, S., Du, C., Liu, J., Luo, X., he, Y., Huang, D., Xu, W., Lei, Y., Huang, W., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114595 · Cited by 9
Devilliers, M., Garrido, D., Poidevin, M., Rubin, T., Rouzic, A. L., & Montagne, J. (2020) · Genetics · doi:10.1093/genetics/iyaa010 · Cited by 9
Unravelling the Interplay between Cardiac Metabolism and Heart Regeneration
Yu, F., Cong, S., Yap, E. P., Hausenloy, D. J., & Ramachandra, C. J. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210300 · Cited by 8
A new view on functions of the lysine demalonylase activity of SIRT5
Nahálková, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121572 · Cited by 8
Epigenetic roles of lysine-specific demethylase 1 (LSD1) in cancer metabolism
Cheng, B., Xu, X., Fan, B., Ma, T., & Yu, B. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104397 · Cited by 7
Salarvandian, S., Digaleh, H., Khodagholi, F., Javadpour, P., Asadi, S., Zaman, A. A. O., & Dargahi, L. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115399 · Cited by 7
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
Alam, R., Reva, A., Edwards, D. G., Lege, B. M., Munoz-Arcos, L. S., Reduzzi, C., Singh, S., Hao, X., Wu, Y.-H., Tian, Z., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0543 · Cited by 10
Gene expression and prognosis of sirtuin family members in ovarian cancer
Zeng, Z., Huang, Y., Li, Y., Huang, S., Wang, J., Tang, Y., & Jiang, Y. (2020) · Medicine · doi:10.1097/md.0000000000020685 · Cited by 7
Iorio, M. C., Ganesh, N. U., Luise, M. D., Porcelli, A. M., Gasparre, G., & Kurelac, I. (2021) · Cancers · doi:10.3390/cancers13215447 · Cited by 7
He, J., Feng, L., Yang, H., Gao, S., Dong, J., Lu, G., Liu, L., Zhang, X., Zhong, K., Guo, S., et al. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12584 · Cited by 6
Sun, R., Zhang, Y., Ma, S., Qi, H.-T., Wang, M., Duan, J.-H., Ma, S., Zhu, X., Li, G., & Wang, H. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12321 · Cited by 7
Lin, S., Teng, L.-Z., Lin, Y., Miao, L., Ge, X., Hao, J.-Y., Huang, X., & Liu, B. (2019) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2019.01.010 · Cited by 7
Advances of SIRT4 in cancer metabolism and therapy
Yue, X., Shi, Y., & Luo, Q. (2023) · Pediatric Discovery · doi:10.1002/pdi3.17 · Cited by 6
Watari, K., Nishitani, A., Shibata, T., Noda, M., Kawahara, A., Akiba, J., Murakami, Y., Yano, H., Kuwano, M., & Ono, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10161 · Cited by 6
Glenske, K., Schaepe, K., Wieck, A., Failing, K., Werner, J., Rohnke, M., Wenisch, S., & Mazurek, S. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100707 · Cited by 6
Farnesysltransferase Inhibitor Prevents Burn Injury-Induced Metabolome Changes in Muscle
Nakazawa, H., Wong, L. P., Shelton, L. M., Sadreyev, R. I., & Kaneki, M. (2022) · Metabolites · doi:10.3390/metabo12090800 · Cited by 6
Fabritiis, S. D., Valentinuzzi, S., Piras, G., Cicalini, I., Pieragostino, D., Pagotto, S., Perconti, S., Zucchelli, M., Schena, A., Taschin, E., et al. (2023) · Oncogenesis · doi:10.1038/s41389-023-00456-4 · Cited by 6
Goodstein, T. A., Yang, Y., Runcie, K. D., Srinivasan, R., & Singer, E. A. (2023) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000939 · Cited by 6
Lipid Metabolism in Relation to Carbohydrate Metabolism
Akiki, P., Delamotte, P., & Montagne, J. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_821 · Cited by 7
mTORC1 Controls Synthesis of Its Activator GTP
Benjamin, D., & Hall, M. N. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.032 · Cited by 6
Thyroid cancer cell metabolism: A glance into cell culture system-based metabolomics approaches
Abooshahab, R., Razavi, F., Ghorbani, F., Hooshmand, K., Zarkesh, M., & Hedayati, M. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.113936 · Cited by 5
Yang, G., Xiang, J., Yang, X., Liu, X., Li, Y.-C., Li, L., Kang, L., Liang, Z., & Yang, S. (2024) · eLife · doi:10.7554/elife.98524.3 · Cited by 5
Tharayil, J. S., Kandettu, A., & Chakrabarty, S. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167691 · Cited by 5
The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia—A Promising Road Ahead
Strzałka, P., Krawiec, K. M., Wiśnik, A., Jarych, D., Czemerska, M., Zawlik, I., Pluta, A., & Wierzbowska, A. (2025) · Cancers · doi:10.3390/cancers17061009 · Cited by 5
Sirtuin Modulation as Novel Neuroprotective Strategy for Alzheimer’s Disease
Polito, L., Biella, G., & Albani, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00008-9 · Cited by 5
Role of sirtuins in esophageal cancer: Current status and future prospects
Otsuka, R., Hayano, K., & Matsubara, H. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i4.794 · Cited by 7
Glutamate Metabolism Regulates Immune Escape of Glioma
Cai, Y., Guo, T., Wang, Y., & Du, J. (2018) · Madridge Journal of Immunology · doi:10.18689/mjim-1000113 · Cited by 5
Targeting glutaminase and mTOR
Tanaka, K., Sasayama, T., & Kohmura, E. (2015) · Oncotarget · doi:10.18632/oncotarget.5263 · Cited by 5
Liang, T., Gu, C., Fang, J., Xu, D., Wang, Z., Chiappini, C., & Hu, N. (2025) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2025.118250 · Cited by 4
Park, J. W., Tyl, M. D., & Cristea, I. M. (2023) · Biomolecules · doi:10.3390/biom13050869 · Cited by 4
Li, Y., Guan, Z., Hu, S., Huang, Z., He, D., Cheng, X., Song, T., Mo, C., Xiao, M., Huang, Y. M., et al. (2023) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2022-0080 · Cited by 4
Bispo, D. S. C., Fabris, V. T., Lamb, C. A., Lanari, C., Helguero, L. A., & Gil, A. M. (2020) · Biomolecules · doi:10.3390/biom10091242 · Cited by 4
Moving towards a novel therapeutic strategy for hyperammonemia that targets glutamine metabolism
Fukui, K., Takahashi, T., Matsunari, H., Uchikura, A., Watanabe, M., Nagashima, H., Ishihara, N., Kakuma, T., Watanabe, Y., Yamashita, Y., et al. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12540 · Cited by 4
Adaptive Benefits of Storage Strategy and Dual AMPK/TOR Signaling in Metabolic Stress Response
Pfeuty, B., & Thommen, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160247 · Cited by 4
Cancer Biology and the Principles of Targeted Cancer Drug Discovery
Hillmann, P., Schmitz, D., Mestan, J., D'Allonzo, S., & Fabbro, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12390-x · Cited by 4
Inhibition of the mTORC1/NF‐κB Axis Alters Amino Acid Metabolism in Human Hepatocytes
Zhang, M., Fu, Y., Chen, Y., Ma, Y., Guo, Z., Wang, Y., Hao, H., Fu, Q., & Wang, Z. (2021) · BioMed Research International · doi:10.1155/2021/8621464 · Cited by 4
Therapeutic strategies for treatment of pulmonary lymphangioleiomyomatosis
Krymskaya, V. P. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.953481 · Cited by 4
Yang, W., van de Ven, R. A. H., & Haigis, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813499-3.00008-3 · Cited by 4
Self-citationZoraiz, K., Attique, M., Shahbaz, S., Ahmed, M. W., Kayani, M. A., & Mahjabeen, I. (2021) · Future Oncology · doi:10.2217/fon-2020-1155 · Cited by 4
Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ
Ryu, H. J., & Koo, J. S. (2022) · Neoplasma · doi:10.4149/neo_2022_220103n3 · Cited by 4
Masisi, B. K., Ansari, R. E., Alfarsi, L. H., Fakroun, A., Erkan, B., Ibrahim, A., Toss, M. S., Ellis, I. O., Rakha, E. A., & Green, A. R. (2024) · Cancers · doi:10.3390/cancers16111949 · Cited by 3
The mTOR Complexes in Cancer Cell Metabolism
Lynch, T. P., Moloughney, J. G., & Jacinto, E. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-34211-5_2 · Cited by 3
Sirtuins and cellular metabolism in cancers
Dong, Z., & Cui, H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00008-5 · Cited by 3
Liao, K., Zhang, Q., Qiu, Y., Zhu, Y., Liu, Y., Huang, H., Chen, D., Ma, B., Zhang, L., Ran, Z., et al. (2023) · Aquaculture Research · doi:10.1155/2023/6666946 · Cited by 4
Involvement of mTOR signaling in physiopathology and its potential therapeutic interventions
Martín-Bocanegra, I., Horne, T. L., Maqueda-Hernández, B., Navarro‐Villarán, E., & Muntané, J. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0024 · Cited by 3
Genetic Interactions of Mitochondrial Sirtuins in Brain Tumorigenesis
Haq, M. F. U., Kayani, M. A., Arshad, T., Anwar, R. A. H., Saeed, N., Shafique, R., Abbasi, S. F., Ahmed, M. W., & Mahjabeen, I. (2022) · Future Oncology · doi:10.2217/fon-2021-0264 · Cited by 3
Peptide Microarrays for Profiling of Epigenetic Targets
Masch, A., Reimer, U., Zerweck, J., & Schutkowski, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801080-8.00009-0 · Cited by 3
Cancer RNome: Evolution and Sustenance
Arora, M., & Kaul, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1568-8_3 · Cited by 3
Therapeutic Targeting of Glutamine Metabolism in Colorectal Cancer
Ratre, Y. K., Verma, H. K., Mehta, A., Soni, V. K., Sonkar, S. C., Shukla, D., Ekka, A., Prajapati, S. K., Mahilkar, S., & Vishvakarma, N. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-64668-4_15 · Cited by 4
Sirtuins, healthspan, and longevity in mammals
Kumar, S., Giblin, W., & Lombard, D. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-815962-0.00005-6 · Cited by 2
Li, Z., & Vacanti, N. M. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00290 · Cited by 3
Hampel, N., Georgy, J., Mehrabipour, M., Lang, A., Lehmkuhl, I., Scheller, J., Ahmadian, M. R., Floss, D. M., & Piekorz, R. P. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13715 · Cited by 3
Devilliers, M., Garrido, D., Poidevin, M., Rubin, T., Rouzic, A. L., & Montagne, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/606699 · Cited by 3
Singh, A., Fan, Y., Cakal, S. D., Amann, T., Hansen, A. H., Borth, N., Lee, G. M., Kildegaard, H. F., & Andersen, M. R. (2022) · doi:10.22541/au.164167102.22702519/v1 · Cited by 2
Avila, M. N., Jung, S., Satterstrom, F. K., Fu, J. M., Levy, T., Sloofman, L. G., Klei, L., Pichardo, T., Stevens, C. R., Cusick, C. M., et al. (2025) · medRxiv · doi:10.1101/2024.12.27.24319460 · Cited by 3
Dipeptide alanine-glutamine ameliorates retinal neurodegeneration in an STZ-induced rat model
Zhang, Y., Wei, M., Wang, X., Xu, Y., Zong, R., Lin, X., Li, S., Chen, W., Liu, Z., & Chen, Q. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1490443 · Cited by 2
Oxidative stress and cancer metabolism: From pathogenesis to therapeutic opportunities
Agnihotri, T. G., Gomte, S. S., Rout, B., Peddinti, V., Maharana, S. K., Yallappa, D., & Jain, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00006-5 · Cited by 3
PTSD and appetite dysregulation: mTOR-dependent modulation of fear memory and satiety circuits
Krattli, S. N., Li, A. S., & McLachlan, C. S. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106495 · Cited by 2
Yang, J., Chen, S., Zeng, T., ZHANG, Y., Li, Z., & Li, H. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101470 · Cited by 2
Lee, H., Hah, Y., Cheon, S. Y., Won, S. J., Yim, C. D., Ryu, S., Lee, S. J., Seo, J., & Park, J. J. (2024) · European Thyroid Journal · doi:10.1530/etj-24-0079 · Cited by 2
Cantó, C., & Houtkooper, R. H. (2016) · Springer eBooks · doi:10.1007/978-94-024-0962-8_10 · Cited by 2
When Cancer Cells Are Given Lemo[NH3]s, They Make Lemo[NH3]ade
Shan, M., & Lyssiotis, C. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.008 · Cited by 2
Metadata
- Authors
- Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., Henske, E. P., Haigis, M. C., Cantley, L. C., Stephanopoulos, G., Yu, J., & Blenis, J.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Blenis, John
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 153
- Issue
- 4
- Pages
- 840-854
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3684628
- OpenAlex
- W2033228549
- Cited by
- 586
- References
- 59
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 52 · 2023: 37 · 2022: 47 · 2021: 42 · 2020: 49 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 55 · 2015: 56 · 2014: 52 · 2013: 13
- FWCI
- 26.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2021-04-15)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Glenn Foundation for Medical Research
- Pfizer
- University of Pennsylvania
- Johns Hopkins University
- Life Sciences Research Foundation
- National Research Foundation
- Deutsche Forschungsgemeinschaft
- Fondation pour la Recherche Médicale
- National Research Foundation of Korea
- National Institutes of Health
- National Institute on Aging (R01AG032375, AG032375)
- National Heart, Lung, and Blood Institute (R01HL098216, R01HL121266, HL098216)
- National Cancer Institute (R01CA160458)
- National Institute of General Medical Sciences (GM51405, R01GM051405)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- mTORC1, SIRT4, glutamine metabolism, glutamine anaplerosis, glutamate dehydrogenase, ATF4, proteasomal degradation, cell proliferation, cancer metabolism, nutrient metabolism, tumor suppression, TCA cycle
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Animals, Embryo, Mammalian, Energy Metabolism, Glutamate Dehydrogenase, Glutamine, Humans, Neoplasm Transplantation, Neoplasms, Transcription, Genetic, Transplantation, Heterologous, Mitochondrial Proteins, Tumor Suppressor Proteins, Sirtuins, Multiprotein Complexes, Cell Proliferation, Mice, Activating Transcription Factors, Ubiquitination, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review